Paladin Advisory Group’s Organon & Co OGN Stock Holding History

Paladin Advisory Group’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,364	Closed	-$38.1K	–	425
2022 Q4	$38.1K	Sell	1,364 -22	-2%	-$563	0.03%	167
2022 Q3	$32K	Buy	1,386 +6	+0.4%	+$181	0.03%	178
2022 Q2	$46K	Buy	+1,380	New	+$48.3K	0.04%	165
2022 Q1	–	Sell	-1,341	Closed	-$40K	–	439
2021 Q4	$40K	Buy	+1,341	New	+$43.7K	0.03%	189

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Paladin Advisory Group's OGN Position: Q2 2023 in Review

Paladin Advisory Group sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 1,373 shares — an estimated $32.3K sold.

Paladin Advisory Group first reported a position in OGN in Q1 2022 and held it in 2 quarters. The position peaked at $48K in Q1 2022. 727 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

Paladin Advisory Group reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
Paladin Advisory Group sold 1,373 Organon & Co shares in Q2 2023, an estimated $32.3K.
Paladin Advisory Group first reported a position in Organon & Co in Q1 2022 and held it in 2 quarters.
Paladin Advisory Group's Organon & Co position peaked at $48K in Q1 2022.
727 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on Paladin Advisory Group's 13F filing for Q2 2023, filed 3 Aug 2023.